Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology • 1998 | View Paper
“The combination of only 1 μg/mL of epicatechin plus 10 μg/mL of EGCG displayed synergistic effects on growth inhibition and induction of apoptosis.”
“The amounts of EGCg required to inhibit by both criteria was reduced 10 times by combination with inactive catechins such as (-)-epicatechin (EC), (-)-epigallocatechin (EGC) or (-)-epicatechin-3-gallate (ECG).”
“ EGCG potently inhibited proton currents with an IC(50) of 3.7 μM. Other tea catechins, (-)-epigallocatechin, (-)-epicatechin and (-)-epicatechin-3-gallate, were far less potent than EGCG.”
European journal of pharmacology • 2013 | View Paper
“Although other polyphenols present in GTPP, particularly epigallocatechin and epicatechin , lack this activity, they synergistically promoted this action of EGCG.”
Journal of neuroscience research • 2010 | View Paper
“ (-)-Epicatechin exhibited synergistic effects with (-)-epigallocatechin-3-gallate , (-)-epicatechin-3-gallate, and theaflavins against AH109A cell proliferation.”
“Adding EGCG , during the blue light illumination treatment of EC decreased photolytic formation, suggesting that gallate-type catechins can suppress the photosensitive oxidation of EC.”